Counteracting neuroinflammation in experimental Parkinson’s disease favors recovery of function: effects of Er-NPCs administration

BACKGROUND: Parkinson’s disease (PD) is the second most common neurodegenerative disease, presenting with midbrain dopaminergic neurons degeneration. A number of studies suggest that microglial activation may have a role in PD. It has emerged that inflammation-derived oxidative stress and cytokine-d...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Neuroinflammation
Egile Nagusiak: Carelli, Stephana, Giallongo, Toniella, Gombalova, Zuzana, Rey, Federica, Gorio, Maria Carlotta F., Mazza, Massimiliano, Di Giulio, Anna Maria
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2018
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6271641/
https://ncbi.nlm.nih.gov/pubmed/30501635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-018-1375-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak